くしゃみ発作
WordNet
- a sudden uncontrollable attack; "a paroxysm of giggling"; "a fit of coughing"; "convulsions of laughter" (同)fit, convulsion
- accompanied by or of the nature of paroxysms
PrepTutorEJDIC
- (病気の周期的な)発作《+『of』+『名』》 / (感情・行動などの)激発,発作的行動《+『of』+『名』》
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Paroxysmal sneezing heralding embolic cerebral infarction.
- Then R, Dominguez F, Robbins MS.
- Journal of the American Geriatrics Society.J Am Geriatr Soc.2013 Jan;61(1):168-9. doi: 10.1111/jgs.12052.
- PMID 23311563
- Paroxysmal sneezing after hypothalamic deep brain stimulation for cluster headache.
- Maniyar FH, Starr P, Goadsby PJ.SourceUniversity of California, USA.
- Cephalalgia : an international journal of headache.Cephalalgia.2012 Jun;32(8):641-4. doi: 10.1177/0333102412442412. Epub 2012 Apr 23.
- BACKGROUND: Cluster headache (CH) is the most common of the trigeminal autonomic cephalalgias (TAC), presenting with excruciatingly severe, short-lasting, unilateral headache accompanied by cranial autonomic symptoms. Chronic CH occurs in 10-15% of patients. Deep brain stimulation in the posterior h
- PMID 22529193
- Vernakalant. Too dangerous in atrial fibrillation.
- [No authors listed]AbstractThe usual aim of treatment for patients with symptomatic paroxysmal or recent-onset atrial fibrillation, including after cardiac surgery, is to slow the heart rate. Electrical and drug (amiodarone) cardioversion are other options. Vernakalant, an antiarrhythmic drug, has been authorised in the European Union for rapid reduction of recent-onset atrial fibrillation. It is only available in an injectable form. Vernakalant has not been compared in clinical trials with treatments slowing the heart rate, or with electrical cardioversion. The only available comparison with another antiarrhythmic agent is a clinical pharmacology study versus amiodarone, a slow-acting drug, based on the rate of cardioversion at 90 minutes in 240 patients. As expected, given the brief observation period, the rate was significantly higher with vernakalant (51.7% versus 5.2%). During clinical evaluation, 6 deaths occurred in the vernakalant groups versus none in the other groups (placebo or amiodarone). The main adverse effects of vernakalant are cardiac arrhythmias (ventricular arrhythmia, torsades de pointes, bradycardia) and severe hypotension. Altered taste, sneezing, paraesthesia, nausea and pruritus were frequent, and respiratory and neuropsychological effects were also reported. A trial in atrial flutter was interrupted when cases of cardiogenic shock occurred. Interactions are to be expected with drugs that prolong the QT interval, and also with drugs that lower the heart rate or the blood potassium concentration. In practice, it is better to continue to use amiodarone for drug cardioversion and to avoid using vernakalant.
- Prescrire international.Prescrire Int.2012 May;21(127):119-22.
- The usual aim of treatment for patients with symptomatic paroxysmal or recent-onset atrial fibrillation, including after cardiac surgery, is to slow the heart rate. Electrical and drug (amiodarone) cardioversion are other options. Vernakalant, an antiarrhythmic drug, has been authorised in the Europ
- PMID 22827000
Japanese Journal
- 季節性鼻アレルギーに対する星状神経節ブロック療法が翌年に及ぼした影響について
- 鼻アレルギーを合併した気管支喘息患者に対する鼻用 Beclomethasone dipropionate の臨床効果の検討
Related Pictures
★リンクテーブル★
[★]
- 英
- paroxysmal sneezing
[show details]
くしゃみ発作 : 約 2,750 件
くしゃみ過多 : 約 20 件
発作性くしゃみ : 17 件
[★]
- (医)(寒気などの周期的な)発作。(医)痙攣。激発。発作的活動、激動
- 関
- (adj.)paroxysmal
- 関
- attack、bout、crises、crisis、insult、seizure、stroke
[★]
- 関
- ictal, paroxystic, paroxysm